Treatment of life-threatening type I refractory coeliac disease with long-term infliximab.

Treatment of life-threatening type I refractory coeliac disease with long-term infliximab. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Treatment of life-threatening type I refractory coeliac disease with long-term infliximab. Abstract Text:

G Costantino,A Della Torre,M A Lo Presti,R Caruso,E Mazzon,W Fries,

Whereas medical approach to coeliac disease is well defined, treatment of patients who fail to respond to a gluten-free diet remains still problematic. We describe the case of a 68 years DQ-2 positive male who lost response to a strict gluten-free diet after an initial response over a 3-year period. His conditions became critical despite high dose prednisone treatment. After a careful differential diagnosis, the patient was classified as having a type I refractory coeliac disease and a single infusion of infliximab at 5mg/kg was given with excellent clinical results. However, clinical response was lost despite background therapy with azathioprine. Six months after the single infusion an induction therapy with infliximab and, thereafter, maintenance every 8 weeks was administered with excellent clinical results. Since small bowel histology recovered very slowly treatment was continued over the following 2 years with a return to near normal architecture. This case shows that anti-tumour necrosis factor treatment may be used in carefully selected patients with type I refractory coeliac disease.

Treatment of life-threatening type I refractory coeliac disease with long-term infliximab. Publishing Authors By Initials

G Costantino,A Della Torre,MA Lo Presti,R Caruso,E Mazzon,W Fries,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Treatment of life-threatening type I refractory coeliac disease with long-term infliximab. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Digestive and liver disease : official journal of

VOLUME: 40

Page Numbers: 74-7

Journal Abbreviation:

ISSN: 1590-8658

DAY: 26

MONTH: 03

YEAR: 2007

Treatment of life-threatening type I refractory coeliac disease with long-term infliximab. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100958385

Treatment of life-threatening type I refractory coeliac disease with long-term infliximab. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Treatment of life-threatening type I refractory coeliac disease with long-term infliximab. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Treatment of life-threatening type I refractory coeliac disease with long-term infliximab.

AFFILIATION: Department of Internal Medicine and Medical Therapy, University of Messina, Italy.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Dig Liver Dis

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Treatment of life-threatening type I refractory coeliac disease with long-term infliximab Related Publications

• A RADIOTRACER STUDY OF THE PRODUCTION OF FORMALDEHYDE IN THE PHOTO-OXIDATION OF ETHYLENE IN THE ATMOSPHERE. I. METHOD AND PROCEDURES.
• A RADIOTRACER STUDY OF THE PRODUCTION OF FORMALDEHYDE IN THE PHOTO-OXIDATION OF ETHYLENE IN THE ATMOSPHERE. II. THE EFFECT OF OTHER COMPOUNDS ON YIELD AND CONVERSION.
• Biofilm formation by and antifungal susceptibility of Candida isolates from urine.
• Characterization of a flocculation-like phenotype in Cryptococcus neoformans and its effects on pathogenesis.
• Convergent evolution of human and bovine haptoglobin: partial duplication of the genes.
• Diet-specific social support among rural adolescents.
• Family factors as correlates of diet in relatives of colon cancer patients.
• Fate of sympathetic trunk ganglia after cutting in German meat plants.
• Gastrointestinal manifestations of allergy in children.
• Individual values, learning routines and academic procrastination.
• Lactic acidosis after treatment with linezolid.
• Local diffusion in paramagnetic solutions by NMR relaxometry at one frequency.
• Measurement of staphylococcal enterotoxin B in serum and culture supernatant with a capture enzyme-linked immunosorbent assay.
• Middle school students' perceived access to cigarettes in virginia.
• Modulation of neuronal interactions through neuronal synchronization.
• Mutations induced in Coprinus fimetarius (L) by nitrogen mustard.
• OP25.09: Enlarged jugular lymphatic sacs with thin nuchal translucency at 11-14 weeks' gestation.
• Polyphloretin phosphate; a hyaluronidase inhibitor; and hyaluronidase in prevention of intraperitoneal adhesions; an experimental study in the rabbit.
• Predicting Nursing Facility Transition Candidates Using AID: A Case Study.
• Predictors of a new depression diagnosis among older adults admitted to complex continuing care: implications for the depression rating scale (DRS).
• Someone to lend a hand when you're hurting.
• The Stanford Health Assessment Questionnaire: dimensions and practical applications.
• Treatment of life-threatening type I refractory coeliac disease with long-term infliximab.
• [First trials in dermatology of a new phenothiazine derivative: acepromazine (CB-1522) in the treatment of pruritus.]
• [Juvenile hemorrhage.]
• [Marcoumar in general prevention of puerperal thrombosis.]
• [Mortality of mother and child in our late toxemias.]
• [Not Available.]
• [Skin infarct in thromboembolism prophylaxis.]
• [Skin infarction in thromboembolism prophylaxis.]